Current HIV/AIDS reports · 2026
HIV Infection HIV/AIDS in Türkiye: Current Challenges and Strategic Solutions.
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Omak Tuğçe Başarı, Seydaliyeva Aytan, Madran Bahar, Önal Uğur, Şengel Buket Ertürk, Tigen Elif Tükenmez, Kutlu Selda Sayın, Turan Janet M, Turan Bülent, Inan Asuman, Akalın Halis, Korten Volkan, Gökengin Deniz, Ergönül Önder
Аннотация
PURPOSE OF REVIEW: This review aims to present the current status of the HIV epidemic in Türkiye, to identify the barriers to achieving the Joint United Nations Programme on HIV/AIDS (UNAIDS) 95-95-95 targets, and to propose strategies to overcome these challenges.
RECENT FINDINGS: In Türkiye, HIV-related diagnostic and treatment services are integrated into the general health insurance system, and most contemporary antiretroviral therapy (ART) are available.Treatment initiation and virological suppression rates that approach international targets. However, challenges remain in early diagnosis and prevention, particularly among key populations. Recent epidemiological data also indicate a marked increase in HIV diagnosesamong women and young people while stigma, discrimination, limited access to testing, and low awareness among both the public and healthcare professionals continue to hinder progress. Controlling the HIV epidemic in Türkiye requires strengthening early diagnosis, ensuring equitable access to ART, expanding prevention strategies such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), and implementing multisectoral approaches to reduce stigma and discrimination. Coordinated actions among policymakers, healthcare providers, and community stakeholders will be critical for achieving national and global HIV targets.
RECENT FINDINGS: In Türkiye, HIV-related diagnostic and treatment services are integrated into the general health insurance system, and most contemporary antiretroviral therapy (ART) are available.Treatment initiation and virological suppression rates that approach international targets. However, challenges remain in early diagnosis and prevention, particularly among key populations. Recent epidemiological data also indicate a marked increase in HIV diagnosesamong women and young people while stigma, discrimination, limited access to testing, and low awareness among both the public and healthcare professionals continue to hinder progress. Controlling the HIV epidemic in Türkiye requires strengthening early diagnosis, ensuring equitable access to ART, expanding prevention strategies such as pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP), and implementing multisectoral approaches to reduce stigma and discrimination. Coordinated actions among policymakers, healthcare providers, and community stakeholders will be critical for achieving national and global HIV targets.